Forest Laboratories FRX, +0.25% is sliding $3.05, or 4.2 percent, to $69.05, in afternoon action. Before the opening bell, the company said it has received an approvable letter from the Food and Drug ...

After one of his sons fell into a deep depression, he helped him recover. He later licensed an antidepressant that was a boon to his pharmaceutical company. By Richard Sandomir Months ago, Mr. Icahn ...

(Reuters) - Forest Laboratories Inc asked shareholders to support its board slate at its upcoming annual general meeting and reject an alternative slate proposed by activist shareholder Carl Icahn.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Furiex had 49 options – and Forest Laboratories ...